We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Quantitative Phase Technology Using Silicon Designed to Visualize Cellular Processes

By LabMedica International staff writers
Posted on 16 Oct 2013
Print article
A team of scientists has figured out how to quantitatively observe cellular processes taking place on “lab-on-a-chip” devices in a silicon setting.

The new technology should be useful in drug development as well as disease diagnosis, researchers working on the project. In a study published October 2, 2013, in Nature’s online journal Scientific Reports, the investigators reported that it overcame past limitations on quantitative microscopy through an opaque media by working with a new combination of near infrared light and a technique called quantitative phase imaging. The technology is approximately 10-years old and uses shifts in phases of light, not staining techniques, to aid specimen imaging—warranting the term “label-free.”

“To the best of our knowledge, this is the first demonstration of quantitative phase imaging of cellular structure and function in silicon environment,” said Assistant Professor of physics Dr. Samarendra Mohanty, head of the biophysics and physiology laboratory at University of Texas (UT) at Arlington (USA), and corresponding author of the article.

The UT at Arlington and Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) group of scientists was able to study specimens through a silicon wafer in two cases. In one, they achieved full-field imaging of the features of red blood cells to nanometer thickness accuracy. They observed, in another specimen, the dynamic variation of human embryonic kidney cells in response to variations in salt concentration. Dr. Mohanty believes that his group’s current research on near-infrared quantitative-phase imaging can lead to noninvasive, label-free monitoring of neuronal activities.

“Silicon-based microdevices known as labs-on-a-chip are revolutionizing high throughput analysis of cells and molecules for disease diagnosis and screening of drug effects. However, very little progress has been made in the optical characterization of samples in these systems,” said Dr. Bipin Joshi, a recent graduate and lead author of the study. “The technology we’ve developed is well-suited to meet this need.”

Dr. Barman, now an assistant professor at Johns Hopkins University (Baltimore, MD, USA), stated that this study is an excellent example of the type of research he envisages doing, projects driven by needs of the biomedical community and continually pushing the edge of biophotonic technology. “We envision that this significantly expands the visualization possible in silicon based microelectronic and micromechanical devices,” he said.

Related Links:
University of Texas at Arlington
Massachusetts Institute of Technology


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.